OPSYNVI

MACITENTAN AND TADALAFIL · Actelion Pharmaceuticals US, Inc.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for OPSYNVI, covering 2024-03-22 to 2025-04-02. Get the full timeline:

Most recent: FDA Approved: OPSYNVI — Supplemental Application (Actelion Pharmaceuticals US, Inc.)